Spyre Therapeutics, Inc.

Squarepoint Ops LLC SYRE

Report date

9/30/2020

Quarter

2020 Q3

Filed

11/16/2020

Shares

40,190

Value ($000)

285

Weight

0.0%

2019 Q4 - 2020 Q3 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q3	11/16/2020	285	0.0%	40,190	9/30/2020
2020 Q2	8/14/2020	359	0.0%	38,804	6/30/2020
2020 Q1	5/15/2020	111	0.0%	23,763	3/31/2020
2019 Q4	2/14/2020	368	0.0%	48,222	12/31/2019